Esperion Therapeutics Inc... (ESPR)
NASDAQ: ESPR
· Real-Time Price · USD
2.10
0.05 (2.44%)
At close: Aug 18, 2025, 3:59 PM
2.08
-0.72%
After-hours: Aug 18, 2025, 07:53 PM EDT
Esperion Therapeutics Revenue
Esperion Therapeutics reported an annual revenue of $332.31M, reflecting a 185.66% growth. For the quarter ending June 30, 2025, Esperion Therapeutics generated $82.39M in revenue.
Revenue (ttm)
332.31M
Revenue Growth
185.66%
Price / Sales Ratio
1.24
Revenue / Employee
1.09M
Employees
304
Market Cap
419.42M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 332.31M | +185.66% |
| Dec 31, 2023 | 116.33M | +54.14% |
| Dec 31, 2022 | 75.47M | -3.79% |
| Dec 31, 2021 | 78.45M | -65.52% |
| Dec 31, 2020 | 227.55M | +53.37% |
| Dec 31, 2019 | 148.36M | -19.57% |
| Dec 31, 2018 | 184.47M | +Infinity% |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | n/a |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | -100.00% |
| Dec 31, 2013 | 4.98B | +Infinity% |
| Dec 31, 2012 | 0 | n/a |
| Dec 31, 2011 | 0 | n/a |
| Dec 31, 2002 | 0 | n/a |
| Dec 31, 2001 | 0 | -100.00% |
| Dec 31, 2000 | 2K | +Infinity% |
| Dec 31, 1999 | 0 | n/a |